These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8762731)

  • 21. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Moro D; Bettio D; De Medici C; Morabito F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):769-75. PubMed ID: 9713567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
    Tancer ME; Stein MB; Uhde TW
    Psychoneuroendocrinology; 1990; 15(4):253-9. PubMed ID: 2087535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of growth hormone-releasing hormone and clonidine on growth hormone release in type 1 diabetic patients.
    Giampietro O; Ferdeghini M; Miccoli R; Locatelli V; Cerri M; Yanaihara N; Navalesi R; Müller EE
    Horm Metab Res; 1987 Dec; 19(12):636-41. PubMed ID: 3126122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of the GH responsiveness to GH releasing stimuli by lysine vasopressin in type 1 diabetic subjects.
    Coiro V; Volpi R; Capretti L; Speroni G; Caffarri G; Marchesi C; Chiodera P
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):487-95. PubMed ID: 10583317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder.
    Brambilla F; Perna G; Garberi A; Nobile P; Bellodi L
    Psychoneuroendocrinology; 1995; 20(1):1-9. PubMed ID: 7838898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH.
    Nakamoto JM; Gertner JM; Press CM; Hintz RL; Rosenfeld RG; Genel M
    J Clin Endocrinol Metab; 1986 May; 62(5):822-6. PubMed ID: 3082919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.
    Giustina A; Bossoni S; Bodini C; Cimino A; Pizzocolo G; Schettino M; Wehrenberg WB
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):510-7. PubMed ID: 1759540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation.
    Salat-Baroux J; Rotten D; Alvarez S; Antoine JM
    Fertil Steril; 1993 Nov; 60(5):791-9. PubMed ID: 8224263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth in children with craniopharyngioma following surgery.
    Tiulpakov AN; Mazerkina NA; Brook CG; Hindmarsh PC; Peterkova VA; Gorelyshev SK
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):733-8. PubMed ID: 10209560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
    Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
    Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
    Suri D; Hindmarsh PC; Brain CE; Pringle PJ; Brook CG
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):399-406. PubMed ID: 2147600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine.
    Orio F; Padovano N; Cinquanta L; Colao A; Merola B; Longobardi S; Rossi E; Esposito V; Orio F; Lombardi G
    J Endocrinol Invest; 1995 Jan; 18(1):63-7. PubMed ID: 7759787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly.
    Ho PJ; Friberg RD; Barkan AL
    J Clin Endocrinol Metab; 1992 Sep; 75(3):812-9. PubMed ID: 1517371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.